E-MAIL UPDATES

Click here to join
our Electronic Communications.

Investors & Media

Whats new.

Press releases

Press releases.

Immutep to Host Eftilagimod Alpha Clinical Development Update Global Webcast

March 27th 2019
press releases

Presentation related to webcast 25. March 2019 - Immutep to Present IMP761 Preclinical Results

March 25th 2019
press releases

Immutep Announces United States Patent Grant for Eftilagimod Alpha in Cancer

March 21st 2019
press releases
more

Investor updates

Investor updates.

Investor Update - January 2019

January 31st 2019
investor updates

Investor Update - June 2018

June 19th 2018
investor updates

Investor Update - December 2017

December 21st 2017
investor updates
more

Analyst reports

Analyst reports.

goetzpartners securities - Unlocking the value of LAG-3 in autoimmunity

This research report is intended for use only by persons who qualify as professional investors or eligible counterparties (institutional investors) in the applicable jurisdiction, and not by any private individuals or other persons who qualify as retail clients.

April 23rd 2019
analyst reports

Edison - Encouraging results for efti and IMP761

April 8th 2019
analyst reports

LifeSci Capital - Immute Ltd (IMMP) Positive Signals in Pre-Clinical Studies with IMP761

March 27th 2019
analyst reports
more